GLP-1 diabetes drug neutral for the heart
Extended-release exenatide (Bydureon) is safe for the heart but does not help prevent cardiovascular events in type 2 diabetes, a study published in theNew England Journal of Medicinereports.MedPage Today
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Byetta | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Study